Commercial scale biocatalysis: Myths and realities

被引:122
作者
Rozzell, JD [1 ]
机构
[1] BioCatalyt Inc, Burbank, CA 91506 USA
关键词
biocatalysis; enzyme; biotransformation; chiral intermediates;
D O I
10.1016/S0968-0896(99)00159-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The unique ways in which enzymes are differentiated from other catalysts translate into special advantages. Understanding these advantages is the key toward better matching of biocatalysts needs in industrial chemistry. Specific cases where enzymes and biotransformations have been used successfully at the production scale are examined, permitting the realities of using biocatalysts to be separated from the misconceptions and myths. Five such misconceptions will be examined in the context of examples of some commercially-successful biocatalytic processes. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2253 / 2261
页数:9
相关论文
共 29 条
[1]   APPLICATION OF A PRACTICAL BIOCATALYTIC REDUCTION TO AN ENANTIOSELECTIVE SYNTHESIS OF THE 5H-2,3-BENZODIAZEPINE LY300164 [J].
ANDERSON, BA ;
HANSEN, MM ;
HARKNESS, AR ;
HENRY, CL ;
VICENZI, JT ;
ZMIJEWSKI, MJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (49) :12358-12359
[2]  
[Anonymous], BIOCATALYTIC PRODUCT
[3]   BACTERIA IN ORGANIC-SYNTHESIS - SELECTIVE CONVERSION OF 1,3-DICYANOBENZENE INTO 3-CYANOBENZOIC ACID [J].
BENGISGARBER, C ;
GUTMAN, AL .
TETRAHEDRON LETTERS, 1988, 29 (21) :2589-2590
[4]  
BOMMARIUS AS, 1992, CHIRALITY IND, P371
[5]  
CHEETHAM PSJ, 1987, METHOD ENZYMOL, V136, P432
[6]  
Chibata I, 1976, Methods Enzymol, V44, P739
[7]  
DIERENFELDT S, UNPUB
[8]  
FUSEE MC, 1987, METHOD ENZYMOL, V136, P463
[9]  
GOLDBERG B, 1978, Patent No. 4102746
[10]  
KOBAYASHI M, 1988, APPL MICROBIOL BIOT, V29, P231